Recent US drug pricing reforms adopt international prices shaped by quality-adjusted life-year (QALY)-based assessments, despite longstanding federal prohibitions on using QALYs in coverage and ...
The Medicare Innovation Center has proposed two drug pricing models that would lower the cost of certain drugs to reflect international prices, which are often significantly lower than what U.S.
From 2021 to 2023, the Center for Medicare and Medicaid Innovation, also known as the CMS Innovation Center, tested the Part D Senior Savings (PDSS) model, which lowered Medicare Part D insulin out-of ...
Baker points to long-term data showing that punitive enforcement has not eliminated drug use nor significantly curtailed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results